📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma. (2025)

First Author: Adiamah M

Attributed to: Anticipatory medicine: Can we identify, predict, and target mechanisms of disease relapse in childhood medulloblastoma? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/neuonc/noae179

PubMed Identifier: 39377369

Publication URI: http://europepmc.org/abstract/MED/39377369

Type: Journal Article/Review

Volume: 27

Parent Publication: Neuro-oncology

Issue: 1

ISSN: 1522-8517